Biomerica Inc (Biomerica) develops, manufactures, and markets medical diagnostic products used for the early detection and monitoring of chronic diseases and medical conditions. The company’s diagnostic test kits are used to analyze blood, urine and fecal specimens of the patient to diagnose various diseases and medical complications. It focuses on the development of products for diabetes, gastrointestinal, food intolerances, and esoteric tests by utilizing enzyme immunoassay technology. Biomerica’s diagnostic tests are used by hospitals, clinical laboratories, physician’s offices and consumers around the world. The company distributes products in the Americas, Europe, Asia, and the Middle East. Biomerica is headquartered in Irvin, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Biomerica Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- Biomerica Inc Company Overview
- Biomerica Inc Company Snapshot
- Biomerica Inc Pipeline Products and Ongoing Clinical Trials Overview
- Biomerica Inc - Pipeline Analysis Overview
- Business Description
- Biomerica Inc - Key Facts
- Biomerica Inc - Major Products and Services
- Biomerica Inc Pipeline Products by Development Stage
- Biomerica Inc Pipeline Products Overview
- Hp+detect
- Hp+detect Product Overview
- InFoods - Crohn’s Disease
- InFoods - Crohn’s Disease Product Overview
- InFoods - Depression
- InFoods - Depression Product Overview
- InFoods - Dermatology
- InFoods - Dermatology Product Overview
- InFoods - Functional Dyspepsia
- InFoods - Functional Dyspepsia Product Overview
- InFoods - Gastroesophageal Reflux Disease
- InFoods - Gastroesophageal Reflux Disease Product Overview
- InFoods - Migraine
- InFoods - Migraine Product Overview
- InFoods - Ulcerative Colitis
- InFoods - Ulcerative Colitis Product Overview
- Rapid IgG/IgM Test - COVID-19
- Rapid IgG/IgM Test - COVID-19 Product Overview
- Serological ELISA Test - COVID-19
- Serological ELISA Test - COVID-19 Product Overview
- Biomerica Inc - Key Competitors
- Biomerica Inc - Key Employees
- Biomerica Inc - Key Employee Biographies
- Biomerica Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Biomerica Inc, Recent Developments
- Nov 21, 2024: Biomerica Secures Three Key International Patents for inFoods Technology to Address GERD, Crohn’s Disease, and Ulcerative Colitis
- Sep 04, 2024: The Saudi Food and Drug Authority (SFDA) Approves Biomerica's At Home PSA Screening Test to Detect Early Signs of Prostate Cancer
- Apr 29, 2024: Biomerica and Leading UAE Healthcare Company Forge a Path to Enhanced Colorectal and Breast Screening with Exclusive Multi-Year Distribution Agreement
- Dec 29, 2023: Biomerica Receives 510(k) clearance for Hp Detect Stool Antigen ELISA Test
- Dec 18, 2023: Biomerica Received US FDA 510(k) Clearance for Their Hp Detect ELISA Test Product Designed to Detect the Presence of the H. pylori Bacteria That infects Approximately 35% of the U.S. Population
- Aug 03, 2023: CVS Health to Begin Nationwide In-Store Sales of Biomerica’s EZ Detect Colorectal Disease Screening Test
- Jun 21, 2023: Biomerica Receives Notice of Patent Allowance in China for a Potential Innovative Technology That Includes an Artificial Intelligence (AI) Claim for Predicting Foods That Contain Ingredients That Cause Adverse Reactions in Patients
- Dec 08, 2022: Biomerica receives KFDA and Ministry of Health approval for Colorectal Screening and Breast Screening Tests in Saudi Arabia and UAE
- Sep 29, 2022: Biomerica’s Aware Breast Self Exam and EZ Detect Colon Disease Test now Available on Amazon and fulfilled by Amazon
- Sep 14, 2022: LifeMD expands primary care platform’s diagnostic capabilities with new at-home screening kits For early warning signs of cancer
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- Biomerica Inc Pipeline Products and Ongoing Clinical Trials Overview
- Biomerica Inc Pipeline Products by Equipment Type
- Biomerica Inc Pipeline Products by Indication
- Biomerica Inc, Key Facts
- Biomerica Inc, Major Products and Services
- Biomerica Inc Number of Pipeline Products by Development Stage
- Biomerica Inc Pipeline Products Summary by Development Stage
- Hp+detect - Product Status
- Hp+detect - Product Description
- InFoods - Crohn’s Disease - Product Status
- InFoods - Crohn’s Disease - Product Description
- InFoods - Depression - Product Status
- InFoods - Depression - Product Description
- InFoods - Dermatology - Product Status
- InFoods - Dermatology - Product Description
- InFoods - Functional Dyspepsia - Product Status
- InFoods - Functional Dyspepsia - Product Description
- InFoods - Gastroesophageal Reflux Disease - Product Status
- InFoods - Gastroesophageal Reflux Disease - Product Description
- InFoods - Migraine - Product Status
- InFoods - Migraine - Product Description
- InFoods - Ulcerative Colitis - Product Status
- InFoods - Ulcerative Colitis - Product Description
- Rapid IgG/IgM Test - COVID-19 - Product Status
- Rapid IgG/IgM Test - COVID-19 - Product Description
- Serological ELISA Test - COVID-19 - Product Status
- Serological ELISA Test - COVID-19 - Product Description
- Biomerica Inc, Key Employees
- Biomerica Inc, Key Employee Biographies
- Biomerica Inc, Subsidiaries
- Glossary
- Biomerica Inc Pipeline Products by Equipment Type
- Biomerica Inc Pipeline Products by Development Stage
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- ALPCO Diagnostics
- Calbiotech Inc
- DiscoveRx Corp
- Alfa Scientific Designs Inc
- BG Medicine Inc
- Aalto Scientific Ltd
